VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q74581627 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010853.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q74581627‏
024 ‎‡a 0000-0003-0198-7671‏ ‎‡2 orcid‏
024 ‎‡a 36806604900‏ ‎‡2 scopus‏
024 ‎‡a 56220684100‏ ‎‡2 scopus‏
024 ‎‡a 57189182042‏ ‎‡2 scopus‏
024 ‎‡a 57194052230‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q74581627‏
100 0 ‎‡a L M Rodrigues‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a L M Rodrigues‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's An experimental in vivo model to characterize "heavy legs" symptom in topical formulations.‏
670 ‎‡a Author's Basal transepidermal water loss: right/left forearm difference and motoric dominance.‏
670 ‎‡a Author's Comparative assessment of the performance of two generations of Tewameter: TM210 and TM300.‏
670 ‎‡a Author's Cutaneous biocompatible rutin-loaded gelatin-based nanoparticles increase the SPF of the association of UVA and UVB filters.‏
670 ‎‡a Author's Dietary water affects human skin hydration and biomechanics‏
670 ‎‡a Author's Different lasers reveal different skin microcirculatory flowmotion - data from the wavelet transform analysis of human hindlimb perfusion‏
670 ‎‡a Author's EEMCO-European group on efficacy measurement and evaluation of cosmetics and other products‏
670 ‎‡a Author's EEMCO guidance for the efficacy assessment of antiperspirants and deodorants‏
670 ‎‡a Author's EEMCO guidance for the measurement of skin microcirculation‏
670 ‎‡a Author's In vivo assessment of peripheral vascular function by tcpO₂ and skin blood flow modelling.‏
670 ‎‡a Author's Influence of the time of occlusion on the quantitative parameters obtained by modelling trans-epidermal water loss curves to describe the human cutaneous barrier function in vivo.‏
670 ‎‡a Author's Integrated approach in the assessment of skin compatibility of cosmetic formulations with green coffee oil.‏
670 ‎‡a Author's Is there any barrier impairment in sensitive skin?: a quantitative analysis of sensitive skin by mathematical modeling of transepidermal water loss desorption curves.‏
670 ‎‡a Author's Modeling TEWL-desorption curves: a new practical approach for the quantitative in vivo assessment of skin barrier.‏
670 ‎‡a Author's Observations on the perfusion recovery of regenerative angiogenesis in an ischemic limb model under hyperoxia.‏
670 ‎‡a Author's Oral supplementation with fish oil reduces dryness and pruritus in the acetone-induced dry skin rat model.‏
670 ‎‡a Author's Positive impact of dietary water on in vivo epidermal water physiology‏
670 ‎‡a Author's Quantitative description of human skin water dynamics by a disposition-decomposition analysis‏
670 ‎‡a Author's Quantitative description of human skin water dynamics by a disposition-decomposition analysis (DDA) of trans-epidermal water loss and epidermal capacitance.‏
670 ‎‡a Author's Regarding the quantification of peripheral microcirculation--Comparing responses evoked in the in vivo human lower limb by postural changes, suprasystolic occlusion and oxygen breathing.‏
670 ‎‡a Author's Screening the dermatological potential of <i>plectranthus</i> species components: antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase‏
670 ‎‡a Author's Solvent effects in permeation assessed in vivo by skin surface biopsy‏
670 ‎‡a Author's The revised EEMCO guidance for the in vivo measurement of water in the skin‏
670 ‎‡a Author's Transcutaneous flow related variables measured in vivo: the effects of gender‏
909 ‎‡a (orcid) 0000000301987671‏ ‎‡9 1‏
909 ‎‡a (scopus) 36806604900‏ ‎‡9 1‏
909 ‎‡a (scopus) 56220684100‏ ‎‡9 1‏
909 ‎‡a (scopus) 57189182042‏ ‎‡9 1‏
909 ‎‡a (scopus) 57194052230‏ ‎‡9 1‏
919 ‎‡a eemcoeuropeangrouponefficacymeasurementandevaluationofcosmeticsandotherproducts‏ ‎‡A EEMCO-European group on efficacy measurement and evaluation of cosmetics and other products‏ ‎‡9 1‏
919 ‎‡a experimentalinvivomodeltocharacterizeheavylegssymptomintopicalformulations‏ ‎‡A An experimental in vivo model to characterize "heavy legs" symptom in topical formulations.‏ ‎‡9 1‏
919 ‎‡a basaltransepidermalwaterlossrightleftforearmdifferenceandmotoricdominance‏ ‎‡A Basal transepidermal water loss: right/left forearm difference and motoric dominance.‏ ‎‡9 1‏
919 ‎‡a comparativeassessmentoftheperformanceof2generationsoftewametertm210andtm300‏ ‎‡A Comparative assessment of the performance of two generations of Tewameter: TM210 and TM300.‏ ‎‡9 1‏
919 ‎‡a cutaneousbiocompatiblerutinloadedgelatinbasednanoparticlesincreasethespfoftheassociationofuvaanduvbfilters‏ ‎‡A Cutaneous biocompatible rutin-loaded gelatin-based nanoparticles increase the SPF of the association of UVA and UVB filters.‏ ‎‡9 1‏
919 ‎‡a dietarywateraffectshumanskinhydrationandbiomechanics‏ ‎‡A Dietary water affects human skin hydration and biomechanics‏ ‎‡9 1‏
919 ‎‡a differentlasersrevealdifferentskinmicrocirculatoryflowmotiondatafromthewavelettransformanalysisofhumanhindlimbperfusion‏ ‎‡A Different lasers reveal different skin microcirculatory flowmotion - data from the wavelet transform analysis of human hindlimb perfusion‏ ‎‡9 1‏
919 ‎‡a eemcoguidancefortheefficacyassessmentofantiperspirantsanddeodorants‏ ‎‡A EEMCO guidance for the efficacy assessment of antiperspirants and deodorants‏ ‎‡9 1‏
919 ‎‡a eemcoguidanceforthemeasurementofskinmicrocirculation‏ ‎‡A EEMCO guidance for the measurement of skin microcirculation‏ ‎‡9 1‏
919 ‎‡a invivoassessmentofperipheralvascularfunctionbytcpo2andskinbloodflowmodelling‏ ‎‡A In vivo assessment of peripheral vascular function by tcpO₂ and skin blood flow modelling.‏ ‎‡9 1‏
919 ‎‡a influenceofthetimeofocclusiononthequantitativeparametersobtainedbymodellingtransepidermalwaterlosscurvestodescribethehumancutaneousbarrierfunctioninvivo‏ ‎‡A Influence of the time of occlusion on the quantitative parameters obtained by modelling trans-epidermal water loss curves to describe the human cutaneous barrier function in vivo.‏ ‎‡9 1‏
919 ‎‡a integratedapproachintheassessmentofskincompatibilityofcosmeticformulationswithgreencoffeeoil‏ ‎‡A Integrated approach in the assessment of skin compatibility of cosmetic formulations with green coffee oil.‏ ‎‡9 1‏
919 ‎‡a isthereanybarrierimpairmentinsensitiveskinaquantitativeanalysisofsensitiveskinbymathematicalmodelingoftransepidermalwaterlossdesorptioncurves‏ ‎‡A Is there any barrier impairment in sensitive skin?: a quantitative analysis of sensitive skin by mathematical modeling of transepidermal water loss desorption curves.‏ ‎‡9 1‏
919 ‎‡a modelingtewldesorptioncurvesanewpracticalapproachforthequantitativeinvivoassessmentofskinbarrier‏ ‎‡A Modeling TEWL-desorption curves: a new practical approach for the quantitative in vivo assessment of skin barrier.‏ ‎‡9 1‏
919 ‎‡a observationsontheperfusionrecoveryofregenerativeangiogenesisinanischemiclimbmodelunderhyperoxia‏ ‎‡A Observations on the perfusion recovery of regenerative angiogenesis in an ischemic limb model under hyperoxia.‏ ‎‡9 1‏
919 ‎‡a oralsupplementationwithfishoilreducesdrynessandpruritusintheacetoneinduceddryskinratmodel‏ ‎‡A Oral supplementation with fish oil reduces dryness and pruritus in the acetone-induced dry skin rat model.‏ ‎‡9 1‏
919 ‎‡a positiveimpactofdietarywateroninvivoepidermalwaterphysiology‏ ‎‡A Positive impact of dietary water on in vivo epidermal water physiology‏ ‎‡9 1‏
919 ‎‡a quantitativedescriptionofhumanskinwaterdynamicsbyadispositiondecompositionanalysis‏ ‎‡A Quantitative description of human skin water dynamics by a disposition-decomposition analysis‏ ‎‡9 1‏
919 ‎‡a quantitativedescriptionofhumanskinwaterdynamicsbyadispositiondecompositionanalysisddaoftransepidermalwaterlossandepidermalcapacitance‏ ‎‡A Quantitative description of human skin water dynamics by a disposition-decomposition analysis (DDA) of trans-epidermal water loss and epidermal capacitance.‏ ‎‡9 1‏
919 ‎‡a regardingthequantificationofperipheralmicrocirculationcomparingresponsesevokedintheinvivohumanlowerlimbbyposturalchangessuprasystolicocclusionandoxygenbreathing‏ ‎‡A Regarding the quantification of peripheral microcirculation--Comparing responses evoked in the in vivo human lower limb by postural changes, suprasystolic occlusion and oxygen breathing.‏ ‎‡9 1‏
919 ‎‡a screeningthedermatologicalpotentialof1plectranthus1speciescomponentsantioxidantandinhibitorycapacitiesoverelastasecollagenaseandtyrosinase‏ ‎‡A Screening the dermatological potential of <i>plectranthus</i> species components: antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase‏ ‎‡9 1‏
919 ‎‡a solventeffectsinpermeationassessedinvivobyskinsurfacebiopsy‏ ‎‡A Solvent effects in permeation assessed in vivo by skin surface biopsy‏ ‎‡9 1‏
919 ‎‡a transcutaneousflowrelatedvariablesmeasuredinvivotheeffectsofgender‏ ‎‡A Transcutaneous flow related variables measured in vivo: the effects of gender‏ ‎‡9 1‏
919 ‎‡a revisedeemcoguidancefortheinvivomeasurementofwaterintheskin‏ ‎‡A The revised EEMCO guidance for the in vivo measurement of water in the skin‏ ‎‡9 1‏
996 ‎‡2 PTBNP|134372
996 ‎‡2 PTBNP|1416257
996 ‎‡2 LC|n 2010016861
996 ‎‡2 RERO|A013641176
996 ‎‡2 PLWABN|9811568821105606
996 ‎‡2 SUDOC|273954350
996 ‎‡2 DNB|1025729897
996 ‎‡2 LC|no2007041180
996 ‎‡2 ISNI|0000000070198578
996 ‎‡2 PTBNP|1497500
996 ‎‡2 SUDOC|264853571
996 ‎‡2 B2Q|0000819939
996 ‎‡2 BLBNB|000335814
996 ‎‡2 BLBNB|000634510
996 ‎‡2 PTBNP|1556024
996 ‎‡2 NII|DA06618083
996 ‎‡2 DNB|1135983518
996 ‎‡2 DNB|101352411X
996 ‎‡2 PTBNP|1387483
996 ‎‡2 NSK|000698836
996 ‎‡2 BLBNB|000984870
996 ‎‡2 LC|n 2018251018
996 ‎‡2 NII|DA12666557
996 ‎‡2 PTBNP|1430420
996 ‎‡2 DNB|131593757
996 ‎‡2 NUKAT|n 2020205631
996 ‎‡2 DNB|115492755
996 ‎‡2 ISNI|0000000047408282
996 ‎‡2 LC|n 81118981
996 ‎‡2 ISNI|0000000067466228
996 ‎‡2 LC|no2011085884
996 ‎‡2 DNB|1048641686
996 ‎‡2 ISNI|0000000493447804
996 ‎‡2 PTBNP|1474696
996 ‎‡2 DNB|1056243481
996 ‎‡2 ISNI|0000000070127753
996 ‎‡2 BLBNB|000303358
996 ‎‡2 BLBNB|000447835
996 ‎‡2 ISNI|000000004608321X
996 ‎‡2 ISNI|0000000113038620
996 ‎‡2 LC|n 82258683
996 ‎‡2 PTBNP|1393812
996 ‎‡2 ISNI|0000000139357371
996 ‎‡2 ISNI|0000000387499328
996 ‎‡2 DNB|1152924567
996 ‎‡2 ISNI|0000000067622518
996 ‎‡2 BLBNB|001532657
996 ‎‡2 RERO|A003754123
996 ‎‡2 RERO|A003754127
996 ‎‡2 PTBNP|1460940
996 ‎‡2 RERO|A003754124
996 ‎‡2 DNB|171188241
996 ‎‡2 SUDOC|032729146
996 ‎‡2 RERO|A003754128
996 ‎‡2 ISNI|0000000380288325
996 ‎‡2 SUDOC|199391173
996 ‎‡2 J9U|987007369525405171
996 ‎‡2 PTBNP|1471002
996 ‎‡2 BNF|16223263
996 ‎‡2 DNB|1012336883
996 ‎‡2 ISNI|0000000036431997
996 ‎‡2 PTBNP|1601439
996 ‎‡2 RERO|A012129734
996 ‎‡2 SUDOC|273036459
996 ‎‡2 BLBNB|000462965
996 ‎‡2 SUDOC|277399491
996 ‎‡2 PTBNP|1475982
996 ‎‡2 SUDOC|249897687
996 ‎‡2 ISNI|000000049656757X
996 ‎‡2 BNF|13048809
996 ‎‡2 BLBNB|001415274
996 ‎‡2 PTBNP|1896058
996 ‎‡2 DNB|143571443
996 ‎‡2 PTBNP|1185879
996 ‎‡2 LC|nr2002026437
996 ‎‡2 BIBSYS|90963659
996 ‎‡2 ISNI|0000000395345038
996 ‎‡2 BLBNB|000335817
996 ‎‡2 BLBNB|000608893
996 ‎‡2 BLBNB|000525001
996 ‎‡2 DNB|122092637X
996 ‎‡2 PTBNP|1813988
996 ‎‡2 SUDOC|101024932
996 ‎‡2 DNB|1154813010
996 ‎‡2 LC|no2022027292
996 ‎‡2 BLBNB|001591847
996 ‎‡2 ISNI|000000043573539X
996 ‎‡2 DNB|121105113
996 ‎‡2 ISNI|0000000067745817
996 ‎‡2 BLBNB|000335651
996 ‎‡2 RERO|A016587702
996 ‎‡2 PTBNP|284003
996 ‎‡2 LC|n 2016247179
996 ‎‡2 BLBNB|001027925
996 ‎‡2 BLBNB|001134772
996 ‎‡2 SUDOC|271487208
996 ‎‡2 ISNI|000000004271319X
996 ‎‡2 BLBNB|000342386
996 ‎‡2 BLBNB|000467815
996 ‎‡2 ISNI|0000000068392830
996 ‎‡2 PTBNP|226853
996 ‎‡2 NSK|000528925
996 ‎‡2 BNE|XX1420250
996 ‎‡2 ISNI|0000000036687319
996 ‎‡2 DNB|1157350119
996 ‎‡2 PTBNP|1413559
996 ‎‡2 LC|n 2020183990
996 ‎‡2 BLBNB|000198046
996 ‎‡2 BLBNB|001648712
996 ‎‡2 ISNI|0000000078234449
996 ‎‡2 LC|nb2002053110
996 ‎‡2 PTBNP|1470436
996 ‎‡2 LC|no2014057663
996 ‎‡2 PTBNP|1019478
996 ‎‡2 LC|n 85104065
996 ‎‡2 SUDOC|196558948
996 ‎‡2 ISNI|0000000068177882
996 ‎‡2 CAOONL|ncf12108137
996 ‎‡2 DNB|171482956
996 ‎‡2 SUDOC|255071035
996 ‎‡2 PTBNP|1439924
996 ‎‡2 BLBNB|001474825
996 ‎‡2 PTBNP|1701284
996 ‎‡2 J9U|987007350032805171
996 ‎‡2 DNB|1116305062
996 ‎‡2 SUDOC|257904646
996 ‎‡2 SUDOC|195156978
996 ‎‡2 LC|n 80093081
996 ‎‡2 PTBNP|1889510
996 ‎‡2 DNB|1030579024
996 ‎‡2 DNB|1056476249
996 ‎‡2 BLBNB|001486388
996 ‎‡2 PTBNP|1147662
996 ‎‡2 LC|n 96090996
996 ‎‡2 BLBNB|001429966
996 ‎‡2 BLBNB|001569879
996 ‎‡2 DNB|1054933456
996 ‎‡2 PLWABN|9813122912105606
996 ‎‡2 ISNI|0000000070428695
996 ‎‡2 PTBNP|1256084
996 ‎‡2 LC|no2003077007
996 ‎‡2 PTBNP|1923707
996 ‎‡2 PTBNP|1859485
996 ‎‡2 BNF|12368637
996 ‎‡2 PTBNP|919323
996 ‎‡2 ISNI|0000000401534741
996 ‎‡2 SUDOC|069655324
996 ‎‡2 LC|n 87101469
996 ‎‡2 BLBNB|000467444
996 ‎‡2 ISNI|0000000112195069
996 ‎‡2 BLBNB|001120821
996 ‎‡2 LC|no2003037321
996 ‎‡2 DNB|1164038117
996 ‎‡2 DNB|1139132962
996 ‎‡2 LC|n 2006218682
996 ‎‡2 ISNI|0000000081840255
996 ‎‡2 BLBNB|000549926
996 ‎‡2 PTBNP|94483
996 ‎‡2 PTBNP|1776277
996 ‎‡2 PTBNP|1460728
996 ‎‡2 LC|n 98925891
996 ‎‡2 LC|no2021142465
996 ‎‡2 J9U|987007355191205171
996 ‎‡2 LC|n 2014204893
996 ‎‡2 BLBNB|000272266
996 ‎‡2 PTBNP|1207918
996 ‎‡2 ISNI|0000000066405474
996 ‎‡2 PTBNP|1631001
996 ‎‡2 LC|no2001016908
996 ‎‡2 DNB|1076377815
996 ‎‡2 ISNI|0000000428412664
996 ‎‡2 LC|n 2024255199
996 ‎‡2 LC|n 85830287
996 ‎‡2 PTBNP|1424410
996 ‎‡2 PTBNP|1580411
996 ‎‡2 BNF|14460443
996 ‎‡2 ISNI|0000000067668057
996 ‎‡2 BLBNB|000482288
996 ‎‡2 PTBNP|1019505
996 ‎‡2 CAOONL|ncf13686919
996 ‎‡2 DNB|135993644
996 ‎‡2 PTBNP|266371
996 ‎‡2 SUDOC|146529316
996 ‎‡2 LC|no2007048977
996 ‎‡2 ISNI|0000000084139325
996 ‎‡2 ISNI|0000000056598508
996 ‎‡2 NII|DA05163057
996 ‎‡2 DNB|105727559X
996 ‎‡2 BNE|XX4710521
996 ‎‡2 LC|nb2009030317
996 ‎‡2 ISNI|0000000092405558
996 ‎‡2 ISNI|0000000084184097
996 ‎‡2 PTBNP|1479799
996 ‎‡2 BNF|17115154
996 ‎‡2 LC|n 97003799
996 ‎‡2 NKC|xx0272519
996 ‎‡2 BLBNB|000423920
996 ‎‡2 CAOONL|ncf10045052
996 ‎‡2 PTBNP|1420656
996 ‎‡2 NTA|067614574
996 ‎‡2 DNB|1229872736
996 ‎‡2 NUKAT|n 2013204502
996 ‎‡2 PTBNP|168954
996 ‎‡2 DNB|129064747X
996 ‎‡2 ISNI|0000000033274041
996 ‎‡2 PTBNP|73431
996 ‎‡2 BLBNB|001509893
996 ‎‡2 PTBNP|295164
996 ‎‡2 PTBNP|33720
996 ‎‡2 SUDOC|221520899
996 ‎‡2 SUDOC|256997551
996 ‎‡2 BLBNB|000513698
996 ‎‡2 NUKAT|n 2019067033
996 ‎‡2 BLBNB|000240274
996 ‎‡2 LC|no2019115494
996 ‎‡2 BLBNB|000252807
996 ‎‡2 LC|no2022045426
996 ‎‡2 PTBNP|463339
996 ‎‡2 SUDOC|090488679
996 ‎‡2 LIH|LNB:C7K_f_;=BR
996 ‎‡2 DNB|129590150
996 ‎‡2 ISNI|0000000068693473
996 ‎‡2 LC|n 2024255632
996 ‎‡2 BLBNB|000163112
996 ‎‡2 BLBNB|000485103
996 ‎‡2 LIH|LNB:_l_Y_n_;=CD
996 ‎‡2 LC|n 94062616
996 ‎‡2 LC|n 86820109
996 ‎‡2 DNB|1162632283
996 ‎‡2 PTBNP|943663
996 ‎‡2 LC|n 2012211476
996 ‎‡2 NKC|xx0207365
996 ‎‡2 ISNI|0000000068314330
996 ‎‡2 BLBNB|000577658
996 ‎‡2 PTBNP|1865342
996 ‎‡2 LC|no 89010320
996 ‎‡2 RERO|A023656504
996 ‎‡2 ISNI|0000000432234813
996 ‎‡2 NTA|131733656
996 ‎‡2 J9U|987007437071205171
996 ‎‡2 LC|n 2021250388
996 ‎‡2 BLBNB|000279550
996 ‎‡2 J9U|987007428438605171
996 ‎‡2 LC|no2007080724
996 ‎‡2 PTBNP|1933944
996 ‎‡2 ISNI|0000000428249465
996 ‎‡2 BLBNB|000520423
996 ‎‡2 DNB|1047601788
996 ‎‡2 PTBNP|32681
996 ‎‡2 ISNI|0000000069410658
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏